Skip to main content
HBA1C & LAB TESTING

Is HbA1c Always Accurate?

Mostly, yes — but three different things can skew the number, and they call for three different responses.

7 min read
A laboratory technician in a white coat pipetting samples into a rack of test tubes at a lab bench
Photo via hamiltonpaviana / Pixabay (opens in a new tab)

HbA1c is one of the more tightly controlled tests a laboratory runs. It is standardised internationally, laboratories are surveyed against known reference samples, and for most people, most of the time, the number that comes back is a fair reflection of the last three months. So the honest answer to "is it always accurate" is: usually, but not always — and the useful part is knowing what kind of inaccuracy you might be looking at.

Three separate things can push an HbA1c result away from the truth, and they have almost nothing to do with each other. The lab has a normal margin of error. Not every HbA1c machine is equally good. And in some people, the biology the test rests on simply does not hold. Each of those calls for a different response, so it is worth being able to tell them apart.

How much wobble is normal, even in a good lab

Every measurement has a margin, and HbA1c is unusual in that we can put a number on it. The NGSP (opens in a new tab), which standardises HbA1c testing worldwide, publishes results from a survey in which samples of a precisely known value are sent out to laboratories to be run blind. In the first 2025 survey (opens in a new tab), samples with reference values of 5.60%, 6.00%, 7.97%, 8.45% and 9.84% went out, and 96.8% to 98.8% of participating laboratories came back within 6% of the target. Average bias across method groups ran from 0.00 to 0.36 percentage points of HbA1c.

Translated into something you can use: a true HbA1c of 7.0% will quite legitimately be reported as 6.8% or 7.2% by a competent laboratory. That is not an error anyone did anything wrong to cause. It is the ordinary resolution of the test.

Note: Small movements are not news

A change from 7.1% to 7.3% between two tests is within the noise of the measurement. A change from 7.1% to 8.4% is not. If you are trying to see whether something you changed is working, look across two or three tests rather than reading a single small step as a trend.

Not every HbA1c machine is the same machine

The same survey shows how much the method matters. Between-laboratory variation for individual methods ranged from 0.4% to 4.0% — a tenfold spread. Eighteen methods, used by around 60% of participating laboratories, stayed inside the recommended limit on every sample; four methods exceeded it. Both kinds of machine are in use, and a report does not usually tell you which one ran your sample.

This has one practical consequence worth acting on: when you can, get your repeat HbA1c done at the same laboratory as the last one. Comparing a result from one lab against a result from another adds a difference that has nothing to do with your blood sugar, and it is exactly the kind of difference that gets misread as progress or backsliding.

The finger-prick HbA1c machine in the clinic

Point-of-care HbA1c devices — the small desktop analysers used in clinics, pharmacies and screening camps that give a result from a finger-prick in a few minutes — are genuinely useful. They remove the venous draw, the wait, and the second trip. They are also, as a category, less reliable than a laboratory, and the gap is larger than most people assume.

The European Reference Laboratory for Glycohemoglobin tested 19 of these devices (opens in a new tab) against certified reference methods. Only 5 of the 19 met both the IFCC and NGSP quality criteria. Nine met neither — despite most of them holding a valid certificate at the time of testing.

The analytical performance of the devices was very poor overall, with 74% not meeting both IFCC and NGSP criteria. These evaluations were performed under ideal conditions; performance may worsen further when used in a clinical setting.

Caution: Where the distinction actually matters

For tracking a trend you already understand, a point-of-care result is reasonable. If the number is going to diagnose you, or trigger a change in medication, ask for a venous sample sent to an accredited laboratory. The American Diabetes Association's position is that A1C used for diagnosis should be run in an accredited lab on an NGSP-certified method.

When it is your blood, not the machine

The third category is different in kind. Here the machine measures correctly — it just measures something that no longer means what we assume it means. HbA1c reads as a three-month average because red blood cells are assumed to live a fairly standard length of time. When they do not, the number shifts without your glucose shifting.

The ADA's Standards of Care in Diabetes—2026 (opens in a new tab) names the conditions that interfere: haemolytic and other anaemias, glucose-6-phosphate dehydrogenase deficiency, recent blood transfusion, drugs that stimulate red cell production, kidney failure, and pregnancy. It also notes that A1C cannot be measured at all in sickle cell disease or other homozygous haemoglobin variants.

Two of those deserve emphasis in Pakistan. Anaemia is common enough here that it is a live possibility for a large share of people getting tested — we covered which direction each type pushes the result in can anaemia affect your HbA1c result](/blog/can-anemia-affect-hba1c-results). And beta-thalassaemia trait, with an estimated [carrier rate of 5–7% of the population (opens in a new tab), is a haemoglobin variant that interferes with some testing methods and not others.

Kidney disease is the one most often missed. The NGSP (opens in a new tab) states that HbA1c underestimates glycaemic control in people with diabetes on dialysis, where glycated albumin is a more robust indicator — which means a comfortable-looking HbA1c in someone on dialysis should not be taken at face value. Late pregnancy runs the other way: the same source notes HbA1c rises in late pregnancy even without diabetes, because of iron deficiency.

Accurate and complete are not the same thing

One last distinction, because it accounts for more confusion than all of the above put together. A perfectly accurate HbA1c is still an average, and averages hide their own extremes. Someone swinging between 60 and 300 mg/dL and someone sitting steadily at 170 can produce the same result. That is not the test being wrong — it is the test answering a narrower question than the one you had. If your readings and your HbA1c seem to disagree, this is usually why, and it is worth reading [HbA1c high but sugar readings normal](/blog/hba1c-high-but-blood-sugar-readings-normal) before suspecting the laboratory.

If you do not trust a result

  1. 1Check the size of the discrepancy first. A gap of 0.2–0.3 percentage points from what you expected is normal measurement margin, not a problem to investigate.
  2. 2Note whether this test was run at the same laboratory as the last one, and whether either was a finger-prick point-of-care device rather than a venous sample.
  3. 3Tell your doctor about anything that affects red blood cells — known anaemia, thalassaemia trait in the family, a recent transfusion, kidney disease, pregnancy, or a recent course of iron.
  4. 4Bring your own readings for the same period. A discrepancy you can show is far easier to act on than one you can only describe.
  5. 5Ask whether a repeat is worth doing before any treatment decision is made on a number that does not fit.

None of this makes HbA1c a bad test. It remains the most useful single number in diabetes care, and for the large majority of people it is doing exactly what it claims. It is simply not a number to read to two decimal places, or to interpret alone.

Give the lab result something to sit against

An HbA1c is one measurement every few months, with its own margin. A record of your own readings — with dates and times — is what tells you whether the lab number fits the rest of the picture, and what makes a genuine discrepancy visible instead of vague.

Start your sugar diary (opens Diatic on Google Play in a new tab)

Frequently asked questions

Should I repeat the test at a different lab to check it?

It is a reasonable instinct, but a second lab may use a different method, so a difference between the two tells you less than you would hope. If you want a genuine recheck, repeating at the same laboratory removes that variable. Going to a second lab is more useful when you suspect the first result was a one-off handling or processing problem rather than a method difference.

My report shows both a percentage and an mmol/mol figure. Which one matters?

They are the same result in two units — the percentage is the NGSP scale most people and most local guidance use, and mmol/mol is the IFCC scale. Neither is more accurate. Just be consistent about which one you track, so you are not comparing 7.0% against 53 mmol/mol and wondering why they look so different.

Are home HbA1c kits worth buying?

They are the same category of device as the clinic point-of-care analysers, and that evaluation of 19 such devices — where most failed to meet quality criteria under ideal laboratory conditions — is the relevant context. A home kit can give you a rough sense of direction between lab tests, but it is not the number to base a medication decision on, and given what a lab HbA1c costs in Pakistan, the case for buying one is weak.

Sources

  1. European Atherosclerosis Society & European Federation of Clinical Chemistry and Laboratory Medicine — Fasting is not routinely required for determination of a lipid profile (European Heart Journal, 2016) (opens in a new tab)
  2. American Diabetes Association (ADA) — Standards of Care in Diabetes 2026, Section 10: Cardiovascular Disease and Risk Management (opens in a new tab)
  3. Chughtai Lab — Lipid Profile Test Price and Details (opens in a new tab)
  4. Dr Essa Laboratory — Lipid Profile Test Price and Details (opens in a new tab)
  5. MedlinePlus (U.S. National Library of Medicine) — Cholesterol Levels: What You Need to Know (opens in a new tab)
  6. NGSP (National Glycohemoglobin Standardization Program) — Factors that Interfere with HbA1c Test Results (opens in a new tab)
  7. American Diabetes Association (ADA) — Standards of Care in Diabetes 2026, Section 2: Diagnosis and Classification of Diabetes (opens in a new tab)
  8. Diabetes & Metabolism Journal — Glycosylated Hemoglobin in Subjects Affected by Iron-Deficiency Anemia (opens in a new tab)
  9. Nutrients / National Nutrition Survey 2018 — Prevalence and Risk Factors for Iron Deficiency Anemia among Children under Five and Women of Reproductive Age in Pakistan (opens in a new tab)
  10. Molecular epidemiology of beta-thalassemia in Pakistan: Far reaching implications (PMC) (opens in a new tab)
  11. NGSP (National Glycohemoglobin Standardization Program) — HbA1c and Estimated Average Glucose (eAG) (opens in a new tab)
  12. Monnier L, Lapinski H, Colette C — Contributions of Fasting and Postprandial Plasma Glucose Increments to the Overall Diurnal Hyperglycemia of Type 2 Diabetic Patients (Diabetes Care, 2003) (opens in a new tab)
  13. U.S. Food and Drug Administration — Self-Monitoring Blood Glucose Test Systems for Over-the-Counter Use (guidance for industry) (opens in a new tab)
  14. NGSP / College of American Pathologists — GH5 Survey Data commentary, first survey of 2025 (opens in a new tab)
  15. Clinical Chemistry (2025) — Challenges in Hb A1c Point-of-Care Testing: Only 5 of 19 Hb A1c Point-of-Care Devices Meet IFCC and NGSP Certification Criteria on Independent Evaluation (opens in a new tab)
  16. American Diabetes Association (ADA) — Standards of Care in Diabetes 2026, Section 6: Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises (opens in a new tab)
  17. Cleveland Clinic Journal of Medicine — The role of hemoglobin A1c in the assessment of diabetes and cardiovascular risk (opens in a new tab)
  18. American Diabetes Association (ADA) — Standards of Care in Diabetes, Section 6: Glycemic Goals and Hypoglycemia (opens in a new tab)
  19. Interpretation of A1C measurement in sub-Saharan Africa beyond the global A1C-Derived Average Glucose (ADAG) equation (PMC) (opens in a new tab)

Related reading